Wells Fargo analyst Larry Biegelsen upgraded Novocure to Overweight from Equal Weight with a price target of $89, up from $74.
Published first on TheFly
See Insiders’ Hot Stocks on TipRanks >>
Read More on NVCR:
Wells Fargo analyst Larry Biegelsen upgraded Novocure to Overweight from Equal Weight with a price target of $89, up from $74.
Published first on TheFly
See Insiders’ Hot Stocks on TipRanks >>
Read More on NVCR: